AnodyneWiki

β-Hydroxyamphetamine

β-Hydroxyamphetamine
β-Hydroxyamphetamine
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass151.21 g/mol [1]
Melting point190-194 °C [1]
SolubilityFreely soluble [1]
Predicted LogP0.8 [1]
Structural Identifiers
[]
Molecular formulaC9H13NO
IUPAC name2-amino-1-phenylpropan-1-ol
SMILESCC(C(C1=CC=CC=C1)O)N
InChIInChI=1S/C9H13NO/c1-7(10)9(11)8-5-3-2-4-6-8/h2-7,9,11H,10H2,1H3
InChIKeyDLNKOYKMWOXYQA-UHFFFAOYSA-N
CAS number48115-38-4
PubChem CID4786

β-Hydroxyamphetamine (also known as 2-Amino-1-phenyl-1-propanol, 628-077-1, α-(1-aminoethyl)benzyl alcohol, 2-Amino-2-methyl-1-phenylethanol, 2-Amino-1-hydroxy-1-phenylpropane, β-Hydroxy-α-methylphenethylamine, Benzenemethanol, α-(1-aminoethyl)-, Benzenemethanol, a-(1-aminoethyl)-, Dexatrim or (-)-Pseudo Norephedrine) is a stimulant substance of the amphetamine and phenylethanolamine class.

Chemistry

 []

β-Hydroxyamphetamine matches Lipinski's rule of five.

Pharmacology

Mechanism of action []

Phenylpropanolamine acts directly on alpha- and, to a lesser degree, beta-adrenergic receptors in the mucosa of the respiratory tract. Stimulation of alpha-adrenergic receptors produces vasoconstriction, reduces tissue hyperemia, edema, and nasal congestion, and increases nasal airway patency. PPA indirectly stimulates beta-receptors, producing tachycardia and a positive inotropic effect. [1]

Medical side effects []

40 side effects listed on drug labels in (phenylpropanolamine).

  • Anxiety
  • Arrhythmia
  • Ataxia
  • Confusional state
  • Feeling abnormal
  • Constipation
  • Dizziness
  • Somnolence
  • Dyskinesia
  • Dyspnoea
  • Dermatitis
  • Rash
  • Flushing
  • Hallucination
  • Hypersensitivity
  • Hypotension
  • Irritability
  • Renal tubular necrosis
  • Nausea
  • Nervousness
  • Tension
  • Psychotic disorder
  • Tachycardia
  • Tremor
  • Vomiting
  • Urinary retention
  • Agitation
  • Hepatocellular injury
  • Liver injury
  • Urinary hesitation
  • Dysphoria
  • Respiratory depression
  • Pulmonary function test decreased
  • Euphoric mood
  • Vision blurred
  • Blood pressure increased
  • Coordination abnormal
  • Antitussive therapy
  • Serotonin syndrome
  • Insomnia

Indications

  • Ache
  • Body temperature increased
  • Common cold
  • Cough
  • Discomfort
  • Headache
  • Hypersensitivity
  • Nasal congestion
  • Pain
  • Rhinorrhoea
  • Seasonal allergy
  • Sinusitis
  • Sneezing

Subjective effects []

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 4786, β-Hydroxyamphetamine. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/4786

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 09:00:18
drugspromissing (no DrugsPRO reagent data)2026-11-20 09:00:14
erowidmissing (no Erowid substance of that name)2026-11-20 09:00:14
gsrsmissing (no UNII)2026-11-20 09:00:14
hmdbmissing (hmdb.ca refused automated access to HMDB0243518)2026-11-20 09:00:14
keggmissing (no KEGG DRUG entry)2026-11-20 09:00:18
pubchemok2026-11-20 09:00:10
redditmissing (no r/tripreports posts mention it)2026-11-20 09:00:14
siderok2026-11-20 09:00:14
structureok2026-11-20 09:00:14
wikipediamissing (no Wikipedia article with a drug infobox)2026-11-20 09:00:14